Skip to main
AMTX

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Aemetis is currently experiencing a rebound in their India business, with new contracts expected to drive further growth and a potential IPO in 2026. With recent positive progress on all key initiatives, a strong 5-year financial plan in place, and potential approval for expanded E15 fuel usage, dairy digester RNG pathways, and federal Section 45Z production tax credits, there is significant upside potential for the company’s stock. However, it's important to note the risks surrounding its balance sheet/liquidity, political/regulatory factors, and changes in consumer demand for alternative energy.

Bears say

Aemetis is incurring net losses, despite potential revenue growth from positive regulatory developments and its 5-year financial plan to reach $1 billion in revenue in 2026 and $2 billion in 2028. The company's high leverage with relatively low cash reserves raises concerns about liquidity. Lowered revenue and EPS estimates, along with lower than expected Q4 revenue and EPS, also contribute to a negative outlook, as does potential risks such as political and regulatory factors and changes in commodity and crude oil prices.

Aemetis (AMTX) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Strong Buy based on their latest research and market trends.

According to 2 analysts, Aemetis (AMTX) has a Strong Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.